1) Cruz CR, Hanley PJ, Liu H, Torrano V, Lin YF, Arce JA, Gottschalk S, Savoldo B, Dotti G, Louis CU, Leen AM, Gee AP, Rooney CM, Brenner MK, Bollard CM, Heslop HE : Adverse events following infusion of T cells for adoptive immunotherapy : a 10-year experience. Cytotherapy 12 : 743-749, 2010
2) Leen AM, Rooney CM, Foster AE : Improving T cell therapy for cancer. Annu Rev Immunol 25 : 243-265, 2007
3) Eshhar Z, Waks T, Gross G, Schindler DG : Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A 90 : 720-724, 1993
4) Rossig C, Brenner MK : Genetic modification of T lymphocytes for adoptive immunotherapy. Mol Ther 10 : 5-18, 2004
5) Dotti G, Savoldo B, Brenner M : Fifteen years of gene therapy based on chimeric antigen receptors : “are we nearly there yet?”. Hum Gene Ther 20 : 1229-1239, 2009